Company Filing History:
Years Active: 2016-2025
Title: Chien-Liang Glenn Lin: Innovator in EAAT2 Activators
Introduction
Chien-Liang Glenn Lin is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target excitatory amino acid transporter 2 (EAAT2). With a total of 5 patents to his name, Lin's work is paving the way for new therapeutic approaches.
Latest Patents
Among his latest patents, Lin has disclosed innovative compounds that activate EAAT2. These compounds are designed to treat or prevent diseases, disorders, and conditions associated with glutamate excitotoxicity. His research focuses on the potential of these activators to provide new avenues for treatment in various neurological conditions.
Career Highlights
Throughout his career, Lin has worked with prestigious institutions such as The Brigham and Women's Hospital and The Ohio State University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Lin has collaborated with notable colleagues, including Kevin J Hodgetts and Gregory D Cuny. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Chien-Liang Glenn Lin is a prominent figure in the field of biotechnology, with a focus on EAAT2 activators. His innovative work and collaborations continue to influence the development of new therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.